Your browser doesn't support javascript.
loading
Healthcare resource utilization trends in patients with acute myeloid leukemia ineligible for intensive chemotherapy receiving first-line systemic treatment or best supportive care: A multicenter international study.
Ito, Tomoki; Sanford, David; Tomuleasa, Ciprian; Hsiao, Hui-Hua; Olivera, Leonardo José Enciso; Enjeti, Anoop Kumar; Conca, Alberto Gimenez; Del Castillo, Teresa Bernal; Girshova, Larisa; Martelli, Maria Paola; Guvenc, Birol; Bui, Cat N; Delgado, Alex; Duan, Yinghui; Guijarro, Belen Garbayo; Llamas, Cynthia; Lee, Je-Hwan.
Afiliación
  • Ito T; First Department of Internal Medicine, Kansai Medical University, Hirakata, Osaka, Japan.
  • Sanford D; Leukemia/Bone Marrow Transplant Program of BC, Division of Hematology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Tomuleasa C; Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj-Napoca, Romania.
  • Hsiao HH; Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital and Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Olivera LJE; Instituto Nacional de Cancerología, Bogotá, Colombia.
  • Enjeti AK; Calvary Mater Newcastle, University of Newcastle, Waratah, New South Wales, Australia.
  • Conca AG; NSW Health Pathology, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.
  • Del Castillo TB; Section of Hematology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
  • Girshova L; University Hospital Central de Asturias, ISPA, IUOPA, Oviedo, Spain.
  • Martelli MP; Federal State Budgetary Institution "Almazov National Medical Research Centre" of the Ministry of Health of the Russian Federation, St Petersburg, Russia.
  • Guvenc B; Department of Medicine and Surgery - Section of Hematology and Clinical Immunology, Santa Maria della Misericordia" Hospital, Perugia University, Perugia, Italy.
  • Bui CN; Department of Hematology, Cukurova University, Adana, Turkey.
  • Delgado A; AbbVie, Inc., North Chicago, Illinois, USA.
  • Duan Y; AbbVie, Inc., Singapore City, Singapore.
  • Guijarro BG; AbbVie, Inc., North Chicago, Illinois, USA.
  • Llamas C; AbbVie, Inc., Madrid, Spain.
  • Lee JH; AbbVie, Inc., North Chicago, Illinois, USA.
Eur J Haematol ; 109(1): 58-68, 2022 Jul.
Article en En | MEDLINE | ID: mdl-35298049
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Japón